August 26, 2016 2:29 PM ET

Life Sciences Tools and Services

Company Overview of inVentiv Health Inc.

Company Overview

inVentiv Health Inc. provides value-added services to the pharmaceutical and life sciences industries in the U.S. and internationally. The company supports a range of clinical development, communications, and commercialization activities critical to developing new drug products and medical devices. Its inVentiv Clinical segment provides services related to permanent placement, clinical staffing, data collection and management, and functional outsourcing. The inVentiv Communications segment furnishes advertising, communications, and other functionally related services. InVentiv Commercial provides commercialization services, including outsourced product commercialization programs; patient sup...

1 Van de Graaff Drive

Burlington, MA 01803

United States

Founded in 1996

14,000 Employees

Phone:

800-416-0555

Key Executives for inVentiv Health Inc.

Chairman, Chief Executive Officer and Member of Compensation Committee
Age: 60
Chief Financial Officer and Chief Accounting Officer
Age: 47
Executive Vice President and President of Clinical Business Segment
Age: 63
President of Adheris Health
President of InVentiv Health Europe
Compensation as of Fiscal Year 2016.

inVentiv Health Inc. Key Developments

inVentiv Health Inc., Q2 2016 Earnings Call, Aug 12, 2016

inVentiv Health Inc., Q2 2016 Earnings Call, Aug 12, 2016

inVentiv Health Does Not Mulls For IPO

inVentiv Health Inc. does not plan to pursue initial public offering (IPO) of common stock at this time.

inVentiv Health Selected by Pfizer as Preferred Provider for Global Clinical Services

inVentiv Health Inc. announced that it has been selected by Pfizer Inc. as one of its preferred partners in the delivery of clinical operations services to support Pfizer's portfolio. inVentiv Health – comprised of a top-tier CRO is now a preferred partner in Pfizer's sourcing strategy for global clinical operations services. The agreement term is until June 8, 2019, and provides Pfizer with the right to extend the term for up to an additional two years. Financial terms of the agreement were not disclosed. As a preferred provider, inVentiv has expanded its clinical operations presence with Pfizer and is focused on therapeutic excellence in the areas of oncology, pain, neuroscience and respiratory and data and technology-driven efficiencies.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
August 1, 2016
--
Merger/Acquisition
September 1, 2015
inVentiv Patient Access Solutions, LLC
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact inVentiv Health Inc., please visit www.inventivhealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.